Broadcast Med | Dr. Ehsan Malek Shares Near Curative CAR T-Cell Trial for Multiple Myeloma

For the first time, patients on a new CAR T-cell therapy for multiple myeloma are experiencing remission long enough to be cautious deemed cured of their disease.

Ehsan Malek, MD, Director of Multiple Myeloma Translational Research at Roswell Park Comprehensive Cancer Center, says new research shows one-third of patients on BCMA CAR T-cell therapy tested negative for minimal residual disease after five years.

Read more about this study here - https://physicianresources.roswellpar...

Learn more about Dr. Malek here - https://www.roswellpark.org/ehsan-malek

_____

To learn more about how Roswell Park can help you, or to refer your patient, fill out the form below.
https://forms.roswellpark.org/become-...